RECONSTITUTED HIGH-DENSITY-LIPOPROTEIN NEUTRALIZES GRAM-NEGATIVE BACTERIAL LIPOPOLYSACCHARIDES IN HUMAN WHOLE-BLOOD

被引:180
作者
PARKER, TS
LEVINE, DM
CHANG, JCC
LAXER, J
COFFIN, CC
RUBIN, AL
机构
[1] NEW YORK HOSP, CORNELL MED CTR, ROGOSIN INST, NEW YORK, NY 10021 USA
[2] NEW YORK HOSP, CORNELL MED CTR, DEPT BIOCHEM, NEW YORK, NY 10021 USA
[3] NEW YORK HOSP, CORNELL MED CTR, DEPT SURG, NEW YORK, NY 10021 USA
[4] IMMUNE RESPONSE CORP, CARLSBAD, CA 92008 USA
关键词
D O I
10.1128/IAI.63.1.253-258.1995
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We have tested hypotheses relating lipoprotein structure to function as measured by the relative ability to neutralize endotoxin by comparing natural human lipoproteins, a chemically defined form of reconstituted high-density lipoprotein (R-HDL), and a lipid emulsion (Intralipid). The human whole-blood system was used as an in vitro model of lipopolysaccharide (LPS) binding protein and CD14-dependent activation of cytokine production. When lipoproteins were compared on the basis of protein content, R-HDL was most effective in reducing tumor necrosis factor alpha (TNF-alpha) production followed in order by very low density lipoprotein, low-density lipoprotein, Intralipid, and natural HDL. However, when these particles were compared by protein, phospholipid cholesterol, or triglyceride content by stepwise linear regression analysis, only phospholipid was correlated to effectiveness (r(2) = 0.873; P < 0.0001). Anti-CD14 monoclonal antibodies MY4 and 3C10 inhibited LPS binding protein and CD14-dependent activation of TNF-alpha production by LPS at LPS concentrations up to similar to-1.0 ng/ml. R-HDL (2 mg of protein per ml) blocked TNF-alpha production by LPS From both smooth- and rough-type gram-negative bacteria at concentrations up to 100 ng of LPS per ml but had little effect on heat-killed gram-positive Staphylococcus aureus and no effect on other LPS-independent stimuli tested. These results support our hypothesis that LPS is neutralized by binding to phospholipid on the surface of R-HDL and demonstrate that R-HDL is a potent inhibitor of the induction of TNF-alpha by LPS from both rough- and smooth-form gram-negative bacteria in whole human blood.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 45 条
[11]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[12]   INHIBITION OF ENDOTOXIN-INDUCED ACTIVATION OF HUMAN-MONOCYTES BY HUMAN LIPOPROTEINS [J].
FLEGEL, WA ;
WOLPL, A ;
MANNEL, DN ;
NORTHOFF, H .
INFECTION AND IMMUNITY, 1989, 57 (07) :2237-2245
[13]  
FREUDENBERG MA, 1980, INFECT IMMUN, V28, P373
[14]   LIPOPOLYSACCHARIDE-BINDING PROTEIN AS A MAJOR PLASMA-PROTEIN RESPONSIBLE FOR ENDOTOXEMIC SHOCK [J].
GALLAY, P ;
HEUMANN, D ;
LEROY, D ;
BARRAS, C ;
GLAUSER, MP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :9935-9938
[15]   EXPRESSION OF MYELOID DIFFERENTIATION ANTIGENS ON NORMAL AND MALIGNANT MYELOID CELLS [J].
GRIFFIN, JD ;
RITZ, J ;
NADLER, LM ;
SCHLOSSMAN, SF .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (04) :932-941
[16]   CHYLOMICRONS ALTER THE FATE OF ENDOTOXIN, DECREASING TUMOR-NECROSIS-FACTOR RELEASE AND PREVENTING DEATH [J].
HARRIS, HW ;
GRUNFELD, C ;
FEINGOLD, KR ;
READ, TE ;
KANE, JP ;
JONES, AL ;
EICHBAUM, EB ;
BLAND, GF ;
RAPP, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (03) :1028-1034
[17]   HUMAN VERY LOW-DENSITY LIPOPROTEINS AND CHYLOMICRONS CAN PROTECT AGAINST ENDOTOXIN-INDUCED DEATH IN MICE [J].
HARRIS, HW ;
GRUNFELD, C ;
FEINGOLD, KR ;
RAPP, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :696-702
[18]  
HARRIS HW, 1991, J LAB CLIN MED, V118, P186
[19]  
HUBSCH AP, 1993, CIRC SHOCK, V40, P14
[20]  
KOIZUMI J, 1988, J LIPID RES, V29, P1405